Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ammonia | HCID 222 | — |
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Oxazolidine-2,5-dione | HCID 75136 | — |
| Reactant | HCID 20363553 | HCID 20363553 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 20363505 | HCID 20363505 | — |
Reaction Steps
To a solution of 0.5 g of 2-(β-methylsulfonylethyl)amino- 5-chlorobenzophenone in 20 ml of dry methylene chloride is added 0.5 g of oxazolidine-2,5-dione. To the mixture is added 20 ml of ethereal hydrogen chloride under cooling. The mixture is stirred at room temperature. After completion of the reaction, the mixture is poured into ice water, basified with aqueous ammonia and extracted with methylene chloride. The extracts are combined and dried over anhydrous sodium sulfate, and the solvent is removed under reduced pressure. The residue is added with isopropyl alcohol to form crystals. Recrystallization from acetone gives 1-(β-methylsulfonylethyl)-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one as colorless leaflets, m.p. 218° - 219° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04010154 |
|---|
| Source dataset | uspto-grants-1977_03 |
|---|
| ORD ID | ord-1ec4974d8a4f4f478ef3c9b5fc6d19b6 |
|---|
| Source note | uspto-grants-1977_03 |
|---|